Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 33,106 $ 7,385 $ 3,840
Cost of revenue 85,739 37,872 3,168
Gross (loss) profit (52,633) (30,487) 672
Selling, general and administrative expenses 120,467 92,796 43,003
Research and development expenses 43,263 48,079 137,135
Operating loss (216,363) (171,362) (179,466)
Other (expense) income, net:      
Change in fair value of equity investments (7,486) 6,792 0
Change in fair value of liability classified warrants 17,592 3,749 0
Change in fair value of convertible notes 9,101 0 0
Interest expense, net (1,326) (24) (4,852)
Other income 7,335 3,560 62,671
Total other income, net: 25,216 14,077 57,819
Loss before income taxes (191,147) (157,285) (121,647)
Provision for income taxes 11 6 5
Net loss (191,158) (157,291) (121,652)
Other comprehensive (loss) income      
Foreign currency translation adjustment (119) 137 (93)
Total comprehensive loss $ (191,277) $ (157,154) $ (121,745)
Net loss per share:      
Basic (in dollars per share) $ (0.57) $ (0.55) $ (0.50)
Diluted (in dollars per share) $ (0.57) $ (0.55) $ (0.50)
Weighted average shares outstanding      
Basic (in shares) 335,586,934 287,527,234 244,163,821
Diluted (in shares) 335,586,934 287,527,234 244,163,821